63 FDA recalls mention Duloxetine. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Duloxetine.
Reason CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Reason CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Reason CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Reason CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Reason CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Reason CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
Reason CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.